title: Prevention of rheumatic fever: a statement for health professionals by the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the Council on Cardiovascular Disease in the young, the American Heart Association.
authors.affiliation: Office of Scientific Affairs, American Heart Association, Dallas, TX 75231.
authors.forename: A S
authors.initials: AS
authors.lastname: Dajani
authors.forename: A L
authors.initials: AL
authors.lastname: Bisno
authors.forename: K J
authors.initials: KJ
authors.lastname: Chung
authors.forename: D T
authors.initials: DT
authors.lastname: Durack
authors.forename: M A
authors.initials: MA
authors.lastname: Gerber
authors.forename: E L
authors.initials: EL
authors.lastname: Kaplan
authors.forename: H D
authors.initials: HD
authors.lastname: Millard
authors.forename: M F
authors.initials: MF
authors.lastname: Randolph
authors.forename: S T
authors.initials: ST
authors.lastname: Shulman
authors.forename: C
authors.initials: C
authors.lastname: Watanakunakorn
mesh_terms: D000572:American Heart Association; D004334:Drug Administration Schedule; D004697:Endocarditis, Bacterial / Q000517:prevention & control; D006801:Humans; D010406:Penicillins / Q000008:administration & dosage / Q000627:therapeutic use; D011322:Primary Prevention; D012213:Rheumatic Fever / Q000188:drug therapy / Q000517:prevention & control*; D013290:Streptococcal Infections / Q000175:diagnosis / Q000188:drug therapy; D013997:Time Factors; D014481:United States
chemical_list: D010406:Penicillins